Definium Therapeutics, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Equivalents | $257.8M | $273.7M | $99.7M | $142.1M | $133.5M | $80.1M |
| Accounts Receivable | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — |
| Total Current Assets | $419.3M | $281.6M | $103.9M | $146.1M | $137.2M | $81.5M |
| Property, Plant & Equipment | — | — | — | — | — | — |
| Goodwill | $19.9M | $19.9M | $19.9M | $19.9M | $19.9M | $0 |
| Intangible Assets (Excl. Goodwill) | — | $0 | $527.0K | $3.7M | $6.9M | — |
| Total Assets | $440.1M | $302.2M | $124.5M | $170.0M | $164.0M | $81.5M |
| Liabilities | ||||||
| Accounts Payable | $5.3M | $2.0M | $4.1M | $2.1M | $4.2M | $2.0M |
| Total Current Liabilities | $66.7M | $38.8M | $32.2M | $17.9M | $10.4M | $3.0M |
| Long-Term Debt | $40.6M | $21.9M | $14.1M | — | — | — |
| Total Liabilities | $107.8M | $60.7M | $46.4M | $19.1M | $12.3M | $5.7M |
| Stockholders' Equity | ||||||
| Retained Earnings | $-582.7M | $-398.9M | $-290.2M | $-194.5M | $-137.7M | $-44.6M |
| Total Stockholders' Equity | $332.3M | $241.4M | $78.1M | $150.9M | $151.7M | $75.9M |